Entrada Therapeutics, Inc.
Developing intracellular therapeutics for rare neuromuscular diseases via its EEV™ platform.
TRDA | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- ONE DESIGN CENTER PLACE, 2210 BOSTON
- Website:
- https://www.entradatx.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Entrada Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing a new class of intracellular therapeutics to treat devastating diseases. The company's proprietary Endosomal Escape Vehicle (EEV™) platform is designed to enable the efficient delivery of a range of therapeutics, such as biologics, into cells. This technology aims to engage previously inaccessible and undruggable disease-causing targets. Entrada's pipeline spans from discovery to clinical-stage programs, with an initial focus on rare neuromuscular conditions, including Duchenne Muscular Dystrophy (DMD).
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Entrada Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Entrada Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Entrada Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
